（文章来源：科技日报） 在临床应用中，这款设备可实时监测脑卒中急性期缺血半暗带演变，为溶栓、取栓等血管再通治疗提供 精准决策依据，同时在术后持续预警继发性脑血管痉挛、脑水肿等风险；在重症监护室，针对颅脑创 伤、蛛网膜下腔出血等危重患者，可实现长期脑功能状态评估，指导精准治疗。 北京市卫生健康委员会药械处处长张龙表示，这一创新实践印证了"医工深度融合"的重要价值，只有聚 焦临床实际需求，才能让科技创新真正落地生根、惠及民生。 12月6日，记者获悉，中国脑卒中大会已在北京成功举办。大会以"做实基层防控规范指导减残"为主 题，由中华预防医学会、国家卫生健康委百万减残工程专家委员会等联合主办。大会现场，中国科学院 自动化研究所孵化的中科搏锐（北京）科技有限公司，携BRS-800系列无创全脑多通道脑氧监护仪亮 相，成为大会焦点。 相较于传统监测设备，BRS-800系列监护仪具有：独创多通道光学设计，可布设多个监测点，避免局部 监测盲区导致漏诊；实时生成脑血氧参数分布图，帮助医生快速定位脑组织缺氧或灌注异常区域；搭载 先进信号处理算法与定标技术，有效抑制生理噪声干扰。值得一提的是，使用该设备，全程无需穿刺、 无辐射，为患 ...

Core Insights - The article discusses a significant breakthrough in the treatment of advanced cholangiocarcinoma, highlighting a new therapy that dramatically improves patient outcomes [3][4]. Group 1: Clinical Research Findings - A Phase II clinical study led by Professor Wang Peng's team reported an objective response rate (ORR) of 75% for patients with advanced intrahepatic cholangiocarcinoma who failed first-line treatment, compared to approximately 5% previously [3]. - The median progression-free survival (PFS) increased from 2-4 months to 16.8 months, while the overall survival (OS) reached 25.4 months, indicating a substantial improvement in treatment efficacy [3]. - The study utilized a combination of cryoablation, targeted therapy, and immunotherapy, which collectively enhanced the clinical outcomes for patients [3]. Group 2: Future Research and Development - A follow-up multi-center, randomized, controlled clinical study has been initiated to further validate the findings and potentially fill the current gap in effective second-line treatment options for cholangiocarcinoma [4]. - The goal of this subsequent research is to provide higher-level evidence for clinical practice guidelines, thereby improving treatment protocols for cholangiocarcinoma patients [4]. Group 3: Collaboration and Innovation - The establishment of the "Shanghai International Medical Science and Technology Innovation Center - Tumor Precision Intervention Excellence Innovation Center" aims to accelerate the industrialization of medical breakthroughs and enhance the translation of research into clinical practice [6]. - The center will focus on the validated "liver tumor cryoablation" technique and prioritize clinical trials for products developed through this collaboration, promoting a deep integration of medical and engineering disciplines [6].